Cytimmune’s core technology revolves around the use of gold nanoparticles as a platform for targeted drug delivery. These nanoparticles can be conjugated with therapeutic agents, targeting ligands, and imaging markers to create multifunctional systems. The nanoparticles are designed to accumulate specifically in tumor tissues, thereby minimizing the exposure of healthy tissues to toxic drugs.
